Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines in the United Kingdom. Its lead drug candidate consists of OCT461201, a cannabinoid like new chemical entity, which is in phase I clinical trial for potential therapy to peripheral neuropathies and irritable bowel syndrome.… Read more
Oxford Cannabinoid Technologies Holdings Plc - Asset Resilience Ratio
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) has an Asset Resilience Ratio of -8.72% as of October 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2023)
This chart shows how Oxford Cannabinoid Technologies Holdings Plc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Oxford Cannabinoid Technologies Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-243.36K | -8.72% |
| Total Liquid Assets | $-243.36K | -8.72% |
Asset Resilience Insights
- Limited Liquidity: Oxford Cannabinoid Technologies Holdings Plc maintains only -8.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Oxford Cannabinoid Technologies Holdings Plc Industry Peers by Asset Resilience Ratio
Compare Oxford Cannabinoid Technologies Holdings Plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Oxford Cannabinoid Technologies Holdings Plc (2023–2023)
The table below shows the annual Asset Resilience Ratio data for Oxford Cannabinoid Technologies Holdings Plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-04-30 | -13.09% | $-588.58K | $4.50 Million | -- |